CN108065366A - Walnut oil soft capsule health products with effect of supplemented calcium and preparation method thereof - Google Patents
Walnut oil soft capsule health products with effect of supplemented calcium and preparation method thereof Download PDFInfo
- Publication number
- CN108065366A CN108065366A CN201711317695.6A CN201711317695A CN108065366A CN 108065366 A CN108065366 A CN 108065366A CN 201711317695 A CN201711317695 A CN 201711317695A CN 108065366 A CN108065366 A CN 108065366A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- walnut oil
- calcium
- effect
- health products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 37
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 239000011575 calcium Substances 0.000 title claims abstract description 34
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 34
- 235000019498 Walnut oil Nutrition 0.000 title claims abstract description 32
- 239000008170 walnut oil Substances 0.000 title claims abstract description 32
- 230000000694 effects Effects 0.000 title claims abstract description 23
- 230000036541 health Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 13
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011782 vitamin Substances 0.000 claims abstract description 11
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 claims abstract description 10
- 238000000265 homogenisation Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 108010010803 Gelatin Proteins 0.000 claims abstract description 7
- 235000013871 bee wax Nutrition 0.000 claims abstract description 7
- 239000012166 beeswax Substances 0.000 claims abstract description 7
- 229920000159 gelatin Polymers 0.000 claims abstract description 7
- 239000008273 gelatin Substances 0.000 claims abstract description 7
- 235000019322 gelatine Nutrition 0.000 claims abstract description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims description 9
- 239000000047 product Substances 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 3
- 150000007513 acids Chemical class 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract 1
- 235000013619 trace mineral Nutrition 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 23
- 241000700159 Rattus Species 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000037182 bone density Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of walnut oil soft capsule health products with effect of supplemented calcium, the soft capsule content includes 45 65 parts of walnut oil；25 45 parts of calcium carbonate；10 20 parts of farnoquinone；12 parts of beeswax；35 parts of gelatin.The present invention also provides the preparation methods of above-mentioned walnut oil soft capsule health products, include the following steps：Walnut oil is heated to 65 DEG C, is stirred after then adding in beeswax and gelatin and Temperature fall；When temperature is down to 40 DEG C, calcium carbonate and farnoquinone are added in, carries out homogeneous；Raw material after homogenization is added in into vitamine D3, is stirred, speed of agitator is 45 revs/min, when mixing time 1.5 is small；Soft capsule is made with 0.7g/.The present invention is in addition to replenishing the calcium, moreover it is possible to supplement a variety of unsaturated acids and trace element for body, safely and effectively.
Description
Technical field
The present invention relates to technical field of health care food more particularly to effect of supplemented calcium health food and its preparation side
Method.
Background technology
Calcium is one of element that content is most in human body, calcareous to infant development, adolescent immunization power and middle-aged and elderly people
Bone health etc. plays an important role.
Chinese residents vegetalitas food materials account for more than the 80% of daily food materials, and oxalic acid, dietary fiber in vegetalitas food materials
It can prevent calcium absorption.
Though there is substantial amounts of calcium-supplementing preparation in the prior art, many calcium sources have certain toxic side effect, such as calcium chloride pair
Stomach has larger stimulation, and calcium acetate has certain acute toxicity, and calcium gluconate is not suitable for diabetic's use.
The content of the invention
For overcome the deficiencies in the prior art, safer there is effect of supplemented calcium it is an object of the invention to provide a kind of
Walnut oil soft capsule health products.
In order to achieve the above object, the technical solution adopted in the present invention is as follows：
Walnut oil soft capsule health products with effect of supplemented calcium, which is characterized in that soft capsule content includes following weight
The raw material of part：
Further, the soft capsule content further includes the raw material of following parts by weight：
5-20 parts of vitamine D3.
Further, the soft capsule content includes the raw material of following parts by weight：
Further, the calcium carbonate grain size is less than 40nm.
The present invention also provides a kind of walnut oil soft capsule health products preparation method with effect of supplemented calcium, including following step
Suddenly：
1st, walnut oil is heated to 55-65 DEG C, is stirred after then adding in beeswax and gelatin and Temperature fall；
2nd, when temperature is down to 40-45 DEG C, calcium carbonate and farnoquinone are added in, carries out homogeneous；
3rd, the raw material after homogenization is added in into vitamine D3, be stirred, speed of agitator is 45 revs/min, during stirring
Between 1.5 it is small when；
4th, soft capsule is made with 0.7g/.
Further, in the step 1), speed of agitator is 200 revs/min, when mixing time 1 is small.
Further, in the step 2), homogeneous rotating speed is 2800 revs/min, and homogeneous 8 minutes stalls 2 minutes, repeats 5
It is secondary.
Further, the step 2), 3) in, stirring and homogenization in, keep temperature be 38-40 DEG C.
Compared with prior art, the beneficial effects of the present invention are：
1) walnut oil is used as matrix, and walnut oil has a variety of nutriments in itself, the natural anti-oxidation in walnut oil
Agent and aliphatic acid contribute to absorption of the human body to minerals, such as calcium, phosphorus, zinc, rich in natural vitamin A, D, can promote bone
Bone is grown, and plays an important role of to replenish the calcium to skeletal system；In addition to replenishing the calcium, moreover it is possible to supplement a variety of unsaturated acids and micro member for body
Element.
2) calcium uptake is promoted using farnoquinone and vitamine D3, it is safer effective：Farnoquinone is can not in human body
The important element lacked generates sclerotin with calcium, increases bone density jointly；Vitamine D3 can improve absorption of the body to calcium, phosphorus,
The level of plasma calcium and blood plasma phosphorus is made to reach degree of saturation, promotes growth and bone calcification；Walnut oil is given birth to zinc gluconate, dimension
The combination of plain K2 and vitamine D3, collaboration have played the absorption for promoting calcium, generate the effect of sclerotin；.
3) it is less than the calcium carbonate of 40nm using grain size, more conducively absorbs.
4) preparation method of the invention can be such that various raw materials uniformly mix on the premise of nutritional ingredient is not destroyed, walnut oil
Subsequent processing after heating is to be carried out under the temperature conditionss less than its heating temperature, can play walnut oil to greatest extent
The effect of, within the temperature range of 38-40 DEG C, and walnut oil and other components can be made, especially calcium and farnoquinone, dimension life
The effect of combination is fully played after plain D3 mixing.
5) flexible glue capsule formula of the invention, especially calcium content are designed in strict accordance with suitable infant's intake, are suitble to baby
Child and teenager eat, and recommend 0~1 years old baby one time a day, 1 tablet each time；1~10 year old infants and children one time a day, every time 2
Grain；11~17 years old teenagers one time a day, 3 tablets each time；To recommend to be eaten for a long time under edible dosage above, effect of supplemented calcium is good, and
It will not accumulate in vivo and cause excessive or poisoning.
Specific embodiment
In the following, by specific embodiment, the present invention is described further.
Embodiment 1
Walnut oil soft capsule health products with effect of supplemented calcium, soft capsule content include the raw material of following parts by weight：
The grain size of above-mentioned calcium carbonate is less than 40nm.
By the raw material of said ratio, soft capsule is made by the following method：
1) walnut oil is heated to 65 DEG C, is stirred after then adding in beeswax and gelatin and Temperature fall, speed of agitator
For 200 revs/min, when mixing time 1 is small.
2) when temperature is down to 45 DEG C, calcium carbonate and farnoquinone are added in, carries out homogeneous, homogeneous rotating speed is 2800 revs/min,
Homogeneous 8 minutes is stalled 2 minutes, is repeated 5 times；It is 40 DEG C that temperature is kept during homogeneous.
3) raw material after homogenization is added in into vitamine D3, be stirred, speed of agitator is 45 revs/min, during stirring
Between 1.5 it is small when, it is 40 DEG C that temperature is kept during stirring.
4) soft capsule is made with 0.7g/.
Embodiment 2
Walnut oil soft capsule health products with effect of supplemented calcium, soft capsule content include the raw material of following parts by weight：
The grain size of above-mentioned calcium carbonate is less than 40nm.
By the raw material of said ratio, soft capsule is made by the following method：
1) walnut oil is heated to 60 DEG C, is stirred after then adding in beeswax and gelatin and Temperature fall, speed of agitator
For 200 revs/min, when mixing time 1 is small.
2) when temperature is down to 43 DEG C, calcium carbonate and farnoquinone are added in, carries out homogeneous, homogeneous rotating speed is 2800 revs/min,
Homogeneous 8 minutes is stalled 2 minutes, is repeated 5 times；It is 40 DEG C that temperature is kept during homogeneous.
3) raw material after homogenization is added in into vitamine D3, be stirred, speed of agitator is 45 revs/min, during stirring
Between 1.5 it is small when, it is 40 DEG C that temperature is kept during stirring.
4) soft capsule is made with 0.7g/.
Embodiment 3
Walnut oil soft capsule health products with effect of supplemented calcium, soft capsule content include the raw material of following parts by weight：
The grain size of above-mentioned calcium carbonate is less than 40nm.
The raw material that the various embodiments described above are matched, makes soft capsule by the following method：
1) walnut oil is heated to 55 DEG C, is stirred after then adding in beeswax and gelatin and Temperature fall, speed of agitator
For 200 revs/min, when mixing time 1 is small；
2) when temperature is down to 40 DEG C, calcium carbonate and farnoquinone are added in, carries out homogeneous, homogeneous rotating speed is 2800 revs/min,
Homogeneous 8 minutes is stalled 2 minutes, is repeated 5 times；It is 38 DEG C that temperature is kept during homogeneous.
3) raw material after homogenization is added in into vitamine D3, be stirred, speed of agitator is 45 revs/min, during stirring
Between 1.5 it is small when, it is 38 DEG C that temperature is kept during stirring.；
4) soft capsule is made with 0.7g/.
4 proving test of embodiment：
By embodiment 1,2,3 with when preparation method, laboratory sample is made.
Using rat 30, half male and half female is randomly divided into 3 groups, gives the corresponding test specimens of embodiment 1-3 respectively, presses
0.3mg/10g weight is administered, and administration is observed continuously at once and through 14 days, and rat behavior, diet, appearance are normal, no poisoning table
It is now and dead.
Using the 3 month female rat 50 with rats with osteoporosis, 5 groups are randomly divided into, control group is set, is implemented
1 group of example, 2 groups of embodiment, 3 groups of embodiment and calcium carbonate group.In addition to control group, other groups are administered daily by 0.2mg/10g weight,
Raising 8 weeks.
Experiment terminates to measure the bone calcium and bone density of rat femur.As a result such as following table
| Group | Bone density (g/cm2) | Bone calcium (mg/g) |
| 1 group of embodiment | 79.32±4.34 | 0.277±0.008 |
| 2 groups of embodiment | 76.45±6.21 | 0.256±0.005 |
| 3 groups of embodiment | 77.44±5.92 | 0.261±0.006 |
| Calcium carbonate group | 64.82±3.24 | 0.217±0.004 |
| Control group | 56.42±4.78 | 0.182±0.003 |
Experiment display, embodiment 1-3 groups are compared with calcium carbonate group and control group, and there were significant differences.
It will be apparent to those skilled in the art that technical solution that can be as described above and design, make other various
Corresponding change and deformation, and all these changes and deformation should all belong to the protection domain of the claims in the present invention
Within.
Claims (8)
1. the walnut oil soft capsule health products with effect of supplemented calcium, which is characterized in that soft capsule content includes following parts by weight
Raw material：
2. there are the walnut oil soft capsule health products of effect of supplemented calcium as described in claim 1, which is characterized in that soft capsule content
Object further includes the raw material of following parts by weight：
5-20 parts of vitamine D3.
3. there are the walnut oil soft capsule health products of effect of supplemented calcium as claimed in claim 2, which is characterized in that soft capsule content
Object includes the raw material of following parts by weight：
4. the walnut oil soft capsule health products with effect of supplemented calcium as any one of claim 1-3, it is characterised in that：
The calcium carbonate grain size is less than 40nm.
5. the walnut oil soft capsule health products preparation method with effect of supplemented calcium, it is characterised in that include the following steps：
1) walnut oil is heated to 55-65 DEG C, is stirred after then adding in beeswax and gelatin and Temperature fall；
2) when temperature is down to 40-45 DEG C, calcium carbonate and farnoquinone are added in, carries out homogeneous；
3) raw material after homogenization is added in into vitamine D3, be stirred, speed of agitator is 45 revs/min, mixing time 1.5
Hour；
4) soft capsule is made with 0.7g/.
6. there is the walnut oil soft capsule health products preparation method of effect of supplemented calcium as claimed in claim 5, it is characterised in that：Institute
It states in step 1), speed of agitator is 200 revs/min, when mixing time 1 is small.
7. there is the walnut oil soft capsule health products preparation method of effect of supplemented calcium as claimed in claim 5, it is characterised in that：Institute
It states in step 2), homogeneous rotating speed is 2800 revs/min, and homogeneous 8 minutes is stalled 2 minutes, is repeated 5 times.
8. the walnut oil soft capsule health products preparation method with effect of supplemented calcium as any one of claim 5-7, institute
State step 2), 3) in, stirring and homogenization in, keep temperature be 38-40 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711317695.6A CN108065366A (en) | 2017-12-12 | 2017-12-12 | Walnut oil soft capsule health products with effect of supplemented calcium and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711317695.6A CN108065366A (en) | 2017-12-12 | 2017-12-12 | Walnut oil soft capsule health products with effect of supplemented calcium and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108065366A true CN108065366A (en) | 2018-05-25 |
Family
ID=62158293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711317695.6A Pending CN108065366A (en) | 2017-12-12 | 2017-12-12 | Walnut oil soft capsule health products with effect of supplemented calcium and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108065366A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108936687A (en) * | 2018-08-08 | 2018-12-07 | 深圳极醇健康产业股份有限公司 | A kind of soft capsule and preparation method thereof of replenishing vitamins KD calcium |
| CN109602020A (en) * | 2018-12-26 | 2019-04-12 | 广东润源中天生物科技有限公司 | A kind of vitamin K soft capsule and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103736074A (en) * | 2013-11-21 | 2014-04-23 | 荣成百合生物技术有限公司 | Bone mineral density increase health capsule and preparation method thereof |
| CN104705658A (en) * | 2015-04-09 | 2015-06-17 | 四川健之源科技有限公司 | Health food with bone density improving function |
| CN105994693A (en) * | 2016-06-07 | 2016-10-12 | 会同县贤胜油业有限责任公司 | Composition soft capsules for enriching calcium and production method of composition soft capsules |
| CN107375221A (en) * | 2017-07-12 | 2017-11-24 | 广州富诺健康科技股份有限公司 | One kind contains farnoquinone calcium tablet and preparation method thereof |
-
2017
- 2017-12-12 CN CN201711317695.6A patent/CN108065366A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103736074A (en) * | 2013-11-21 | 2014-04-23 | 荣成百合生物技术有限公司 | Bone mineral density increase health capsule and preparation method thereof |
| CN104705658A (en) * | 2015-04-09 | 2015-06-17 | 四川健之源科技有限公司 | Health food with bone density improving function |
| CN105994693A (en) * | 2016-06-07 | 2016-10-12 | 会同县贤胜油业有限责任公司 | Composition soft capsules for enriching calcium and production method of composition soft capsules |
| CN107375221A (en) * | 2017-07-12 | 2017-11-24 | 广州富诺健康科技股份有限公司 | One kind contains farnoquinone calcium tablet and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 李树壮: "《维生素K2：维护骨骼和血管健康的革命性贡献》", 30 September 2013, 中国医药科技出版社 * |
| 李炎: "《食品添加剂制备工艺》", 30 September 2001, 广东科技出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108936687A (en) * | 2018-08-08 | 2018-12-07 | 深圳极醇健康产业股份有限公司 | A kind of soft capsule and preparation method thereof of replenishing vitamins KD calcium |
| CN109602020A (en) * | 2018-12-26 | 2019-04-12 | 广东润源中天生物科技有限公司 | A kind of vitamin K soft capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104430895B (en) | A kind of full nutritional formula and preparation method thereof | |
| CN103431423B (en) | A kind of fresh animal tankage and preparation thereof and eating method | |
| CN101904507B (en) | Ferrous bisglycinate chelate nutritional composition and application thereof | |
| CN112353813A (en) | Vitamin D and vitamin K soft capsules with good calcium supplementing effect | |
| CN106666169A (en) | Alga hair beautifying paste and preparation method thereof | |
| CN106804730A (en) | The formula milk that the suitable standby pregnant phase treated constipation, period of pregnancy women eat can be prevented | |
| CN108065366A (en) | Walnut oil soft capsule health products with effect of supplemented calcium and preparation method thereof | |
| CN107821713A (en) | Collagen mineral complex pressed candy | |
| CN104256588A (en) | Balanced nutrient solution of foods for special medical purpose (FSMP), and preparation method thereof | |
| CN105878397A (en) | Composition capable of regulating transportation stress of cattle and sheep | |
| CN106360691A (en) | Selenium-enriched food suitable for people suffering from osteoporosis and preparation method thereof | |
| CN109156530A (en) | A kind of diatery supplement nutrition packet and its production technology | |
| CN108567937A (en) | One kind is replenished the calcium soft capsule and preparation method thereof | |
| CN105454667A (en) | Feed additive capable of replacing antibiotics and preparation method of feed additive | |
| CN108902719A (en) | A kind of health caring noodles and preparation method thereof | |
| CN102613461B (en) | Rapidly beautifying and weight losing nourishment and preparation method thereof | |
| JP2008237058A (en) | Dietary supplement | |
| CN103211228A (en) | Composition for increasing bone mineral density | |
| CN103238643A (en) | Biological calcium supplement special for flour | |
| CN102450578A (en) | Formulation for celery green health-care steamed buns and preparation process | |
| CN108851037A (en) | A kind of preparation method and its usage of nephrotic syndrome wholefood | |
| CN102845360A (en) | Method for breeding selenium-rich black swan | |
| CN106387340A (en) | High-zinc selenium-enriched additive for laying hen feed, laying hen feeding method and selenium-enriched high-zinc eggs | |
| CN108065404A (en) | Health products and its production method with replenishing vitamins AD effects | |
| CN101313751A (en) | Health food for auxiliary improvement of memory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180525 |